This Week in Startups

Startup Valuations, Biotech’s Crunch & AI’s Massive TAM | E2147

83 snips
Jul 2, 2025
D.A. Wallach, a General Partner at Time BioVentures, focuses on biotech and machine learning. Matt Turck from FirstMark specializes in enterprise software and AI. Astasia Myers of Felicis invests in early-stage AI and cybersecurity. They discuss the biotech sector's struggle amidst a tough market, contrasting it with the booming AI landscape. Virtual doctors and advancements in fertility tech have the potential to revolutionize healthcare. The panel also explores investment trends and the democratization of AI tools—shaping the future of startups.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

AI Sparks Seismic Venture Shift

  • AI is driving a seismic shift with higher quality founders and larger market opportunities.
  • Early-stage rounds have fewer deals but with much larger capital amounts due to AI's market impact.
INSIGHT

Biotech's Capital Market Crisis

  • Biotech faces a "Great Depression" due to closed public markets cutting off IPO exits.
  • Without IPOs, biotech companies struggle to raise the capital needed for clinical development.
ADVICE

Prioritize Marketing Early

  • Founders must prioritize marketing and community development alongside technology.
  • With lower barriers to entry, product awareness is essential to break through market noise.
Get the Snipd Podcast app to discover more snips from this episode
Get the app